Another limitation of this study is that this is an observational study of the association of TLR2, TLR4 and TLR9 polymorphisms, and TLR9 haplotypes with AML risk and the overall survival of AML patients based on a single time-point evaluation. Here, TLR9 is linked to acute myeloid leukemia.